ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,323, issued on Dec. 2, was assigned to Memorial Sloan Kettering Cancer Center (New York).
"Anti-L1-CAM antibodies and uses thereof" was invented by Nai-Kong V. Cheung (New York), Hong Xu (New York), Maya Suzuki-Nishijima (New York), Brandon Nemieboka (New York) and Jason Lewis (New York).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to immunoglobulin-related compositions (e.g., antibodies or antigen binding fragments thereof) that can bind to and neutralize the activity of L1-CAM protein. The antibodies of the present technology are useful in methods for detecting and treating a L1-CAM-positive cancer in a sub...